The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
Open accessAbstract
Since the 1980s, the occurrence of pharmaceuticals and personal care products (PPCPs) as trace environmental pollutants, originating primarily from consumer use and actions rather than manufacturer effluents, continues to become more firmly established. Although PPCPs typically have been identified in surface and ground waters, some are also undoubtedly associated with solid phases such as suspended particulates, sediments, and sewage sludges, despite their relatively high affinity for water. Often amenable to degradation, their continual introduction to waste-receiving waters results from their widespread, continuous, combined use by individuals and domestic animals, giving PPCPs a "pseudo-persistence" in the environment. Little is known about the environmental or human health hazards that might be posed by chronic, subtherapeutic levels of these bioactive substances or their transformation products. The continually growing, worldwide importance of freshwater resources, however, underscores the need for ensuring that any aggregate or cumulative impacts on (or from) water supplies are minimized. Despite the paucity of effects data from long-term, simultaneous exposure at low doses to multiple xenobiotics (particularly non-target-organism exposure to PPCPs), a wide range of proactive actions could be implemented to reduce or minimize the introduction of PPCPs to the environment. Most of these actions fall under what could be envisioned as a holistic stewardship program--overseen by the health care industry and consumers alike. Significantly, such a stewardship program would benefit not just the environment; additional, collateral benefits could automatically accrue, including reducing consumers' medication expenses and improving patient health and consumer safety. In this article, the first of a two-part mini-monograph describing the "green pharmacy," I focus initially on the background behind the imperative for an ecologically oriented stewardship program for PPCPs. I then present a broad spectrum of possible source control/reduction actions, controlled largely by the health care industry, that could minimize the disposition of PPCPs to the environment. This two-part mini-monograph attempts to capture cohesively for the first time the wide spectrum of actions available for minimizing the release of PPCPs to the environment. A major objective is to generate an active dialog or debate across the many disciplines that must become actively involved to design and implement a successful approach to life-cycle stewardship of PPCPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deterministic Nonperiodic Flow
Lorenz, E. N. (1963) · Journal of the Atmospheric Sciences · doi:10.1175/1520-0469(1963)020<0130:dnf>2.0.co;2 · Cited by 19,398
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
To Err Is Human: Building a Safer Health System
(2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,044
Crossing the Quality Chasm: A New Health System for the 21st Century
Baker, A. (2001) · BMJ · doi:10.1136/bmj.323.7322.1192 · Cited by 10,736
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., & Buxton, H. T. (2002) · Environmental Science & Technology · doi:10.1021/es011055j · Cited by 7,953
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Pharmaceuticals and personal care products in the environment: agents of subtle change?
Daughton, C. G., & Ternes, T. A. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s6907 · Cited by 4,705
Self-citationCradle to cradle: remaking the way we make things
(2002) · Choice Reviews Online · doi:10.5860/choice.40-0914 · Cited by 3,829
(1989) · Long Range Planning · doi:10.1016/0024-6301(89)90186-6 · Cited by 3,431
Heberer, T. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00041-3 · Cited by 2,995
Resilience of ecosystems: local surprise and global change.
Holling, C. S. (1985) · IIASA PURE (International Institute of Applied Systems Analysis) · Cited by 1,217
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
Antibacterial agents based on the cyclic d,l-α-peptide architecture
Fernandez-Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A., Wilcoxen, K. M., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938
Pharmaceuticals in the environment : sources, fate, effects and risks
Kümmerer, K. (2008) · FreiDok plus (Universitätsbibliothek Freiburg) · Cited by 911
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review
Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadee, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705
Antibody-Based Bio-Nanotube Membranes for Enantiomeric Drug Separations
Lee, S. B., Mitchell, D. T., Trofin, L., Nevanen, T. K., Söderlund, H., & Martin, C. R. (2002) · Science · doi:10.1126/science.1071396 · Cited by 619
Smith, D. L., Harris, A. D., Johnson, J. A., Silbergeld, E. K., & Morris, J. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082188899 · Cited by 463
Promotion of Prescription Drugs to Consumers
Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012075 · Cited by 420
Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues
(2001) · ACS Symposium Series · doi:10.1021/bk-2001-0791 · Cited by 357
Bain, P. G., Mann, L., & Pirola-Merlo, A. (2001) · Small Group Research · doi:10.1177/104649640103200103 · Cited by 336
Antimicrobial activity of psychotropic drugs
Munoz-Bellido, J. L., Munoz-Criado, S., & Garcı̀a-Rodrı̀guez, J. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00154-5 · Cited by 249
Environmental Degradation and the Tyranny of Small Decisions
Odum, W. E. (1982) · BioScience · doi:10.2307/1308718 · Cited by 241
Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials
Nuovo, J. (2002) · JAMA · doi:10.1001/jama.287.21.2813 · Cited by 241
Miller, G. (2002) · Science · doi:10.1126/science.297.5584.1116 · Cited by 240
Daughton, C. G. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5948 · Cited by 219
Self-citationEnvironmental stewardship and drugs as pollutants
Daughton, C. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11176-7 · Cited by 161
Self-citationAntibiotics in agriculture: When is it time to close the barn door?
Lipsitch, M., Singer, R. S., & Levin, B. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092142499 · Cited by 153
Crain, S. M., & Shen, K.-F. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03010-9 · Cited by 152
Slovic, P. (2001) · Journal of Hazardous Materials · doi:10.1016/s0304-3894(01)00248-5 · Cited by 152
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial
Evans, A. T., Husain, S., Durairaj, L., Sadowski, L. S., Charles‐Damte, M., & Wang, Y. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08597-5 · Cited by 124
Hot spot pollutants: pharmaceuticals in the environment
Dietrich, D. R., Webb, S., & Petry, T. W. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00062-0 · Cited by 114
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
Magnani, M., Rossi, L., Fraternale, A., Bianchi, M., Antonelli, A., Crinelli, R., & Chiarantini, L. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301758 · Cited by 98
Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER
Schowanek, D. R., & Webb, S. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00064-4 · Cited by 83
Straub, J. O. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00210-2 · Cited by 58
Antidepressants in Aquatic Organisms: A Wide Range of Effects
Fong, P. P. (2001) · ACS symposium series · doi:10.1021/bk-2001-0791.ch015 · Cited by 48
The Health of Ecology and the Ecology of Health
Rapport, D. J. (2002) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/20028091056836 · Cited by 19
Epel, D., & Smital, T. (2001) · ACS Symposium Series · doi:10.1021/bk-2001-0791.ch014 · Cited by 10
Community based health and development: the Jamkhed experience
Arole, R. (2001) · Health Promotion Journal of Australia · Cited by 1
Cited by
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?
Boxall, A. B. A., Rudd, M. A., Brooks, B. W., Caldwell, D. J., Choi, K., Hickmann, S., Innes, E., Ostapyk, K., Staveley, J. P., Verslycke, T., et al. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104477 · Cited by 1,363
Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China
Liu, J.-L., & Wong, M.-H. (2013) · Environment International · doi:10.1016/j.envint.2013.06.012 · Cited by 1,357
Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry
Khetan, S. K., & Collins, T. J. (2007) · Chemical Reviews · doi:10.1021/cr020441w · Cited by 1,145
Jelic, A., Gros, M., Ginebreda, A., Cespedes-Sánchez, R., Ventura, F., Petrovic, M., & Barcelo, D. (2011) · Water Research · doi:10.1016/j.watres.2010.11.010 · Cited by 998
Metadata
- Authors
- Daughton, C. G.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-05
- Volume
- 111
- Issue
- 5
- Pages
- 757-774
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2030219777
- Cited by
- 377
- References
- 39
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.